CRM197 is a non-toxic mutant of diphtheria toxin and it's widely used as a carrier protein for conjugate vaccines.
Market Analysis and Insights: Global CRM197 Market
The global CRM197 market size is projected to reach US$ 240.8 million by 2028, from US$ 172.2 million in 2021, at a CAGR of 5.3% during 2022-2028.
Pfizer Inc is one of the most important global manufacturers of CRM197, holds a share of over 85%. North America is the largest market, occupied for over 75%. In terms of type, research grade is the largest segment, with a share of over 85%. And in terms of application, pneumococcal conjugate vaccine segment holds a share of about 90%.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global CRM197 market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global CRM197 market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global CRM197 market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global CRM197 market.
Global CRM197 Scope and Market Size
CRM197 market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global CRM197 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
- Research Grade CRM197
- cGMP Grade CRM197
Segment by Application
- Pneumococcal Conjugate Vaccine
- Meningococcal Polysaccharide Conjugate Vaccine
- Others
By Company
- Pfizer Inc.
- Ligand Pharmaceuticals
- CanSino Biologic
- Beijing Kexing Biology Product
- Scarab Genomics
- Xpress Biologics
- Fina Biosolutions
- Eubiologics
- EirGenix Inc.
By Region
- North America
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
TABLE OF CONTENTS
1 Report Business Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global CRM197 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
- 1.2.2 Research Grade CRM197
- 1.2.3 cGMP Grade CRM197
- 1.3 Market by Application
- 1.3.1 Global CRM197 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 Pneumococcal Conjugate Vaccine
- 1.3.3 Meningococcal Polysaccharide Conjugate Vaccine
- 1.3.4 Others
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global CRM197 Market Perspective (2017-2028)
- 2.2 CRM197 Growth Trends by Region
- 2.2.1 CRM197 Market Size by Region: 2017 VS 2021 VS 2028
- 2.2.2 CRM197 Historic Market Size by Region (2017-2022)
- 2.2.3 CRM197 Forecasted Market Size by Region (2023-2028)
- 2.3 CRM197 Market Dynamics
- 2.3.1 CRM197 Industry Trends
- 2.3.2 CRM197 Market Drivers
- 2.3.3 CRM197 Market Challenges
- 2.3.4 CRM197 Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top CRM197 Players by Revenue
- 3.1.1 Global Top CRM197 Players by Revenue (2017-2022)
- 3.1.2 Global CRM197 Revenue Market Share by Players (2017-2022)
- 3.2 Global CRM197 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Players Covered: Ranking by CRM197 Revenue
- 3.4 Global CRM197 Market Concentration Ratio
- 3.4.1 Global CRM197 Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by CRM197 Revenue in 2021
- 3.5 CRM197 Key Players Head office and Area Served
- 3.6 Key Players CRM197 Product Solution and Service
- 3.7 Date of Enter into CRM197 Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 CRM197 Breakdown Data by Type
- 4.1 Global CRM197 Historic Market Size by Type (2017-2022)
- 4.2 Global CRM197 Forecasted Market Size by Type (2023-2028)
5 CRM197 Breakdown Data by Application
- 5.1 Global CRM197 Historic Market Size by Application (2017-2022)
- 5.2 Global CRM197 Forecasted Market Size by Application (2023-2028)
6 North America
- 6.1 North America CRM197 Market Size (2017-2028)
- 6.2 North America CRM197 Market Size by Type
- 6.2.1 North America CRM197 Market Size by Type (2017-2022)
- 6.2.2 North America CRM197 Market Size by Type (2023-2028)
- 6.2.3 North America CRM197 Market Share by Type (2017-2028)
- 6.3 North America CRM197 Market Size by Application
- 6.3.1 North America CRM197 Market Size by Application (2017-2022)
- 6.3.2 North America CRM197 Market Size by Application (2023-2028)
- 6.3.3 North America CRM197 Market Share by Application (2017-2028)
- 6.4 North America CRM197 Market Size by Country
- 6.4.1 North America CRM197 Market Size by Country (2017-2022)
- 6.4.2 North America CRM197 Market Size by Country (2023-2028)
- 6.4.3 United States
- 6.4.4 Canada
7 Europe
- 7.1 Europe CRM197 Market Size (2017-2028)
- 7.2 Europe CRM197 Market Size by Type
- 7.2.1 Europe CRM197 Market Size by Type (2017-2022)
- 7.2.2 Europe CRM197 Market Size by Type (2023-2028)
- 7.2.3 Europe CRM197 Market Share by Type (2017-2028)
- 7.3 Europe CRM197 Market Size by Application
- 7.3.1 Europe CRM197 Market Size by Application (2017-2022)
- 7.3.2 Europe CRM197 Market Size by Application (2023-2028)
- 7.3.3 Europe CRM197 Market Share by Application (2017-2028)
- 7.4 Europe CRM197 Market Size by Country
- 7.4.1 Europe CRM197 Market Size by Country (2017-2022)
- 7.4.2 Europe CRM197 Market Size by Country (2023-2028)
- 7.4.3 Germany
- 7.4.4 France
- 7.4.5 U.K.
- 7.4.6 Italy
- 7.4.7 Russia
- 7.4.8 Nordic Countries
8 Asia-Pacific
- 8.1 Asia-Pacific CRM197 Market Size (2017-2028)
- 8.2 Asia-Pacific CRM197 Market Size by Type
- 8.2.1 Asia-Pacific CRM197 Market Size by Type (2017-2022)
- 8.2.2 Asia-Pacific CRM197 Market Size by Type (2023-2028)
- 8.2.3 Asia-Pacific CRM197 Market Share by Type (2017-2028)
- 8.3 Asia-Pacific CRM197 Market Size by Application
- 8.3.1 Asia-Pacific CRM197 Market Size by Application (2017-2022)
- 8.3.2 Asia-Pacific CRM197 Market Size by Application (2023-2028)
- 8.3.3 Asia-Pacific CRM197 Market Share by Application (2017-2028)
- 8.4 Asia-Pacific CRM197 Market Size by Region
- 8.4.1 Asia-Pacific CRM197 Market Size by Region (2017-2022)
- 8.4.2 Asia-Pacific CRM197 Market Size by Region (2023-2028)
- 8.4.3 China
- 8.4.4 Japan
- 8.4.5 South Korea
- 8.4.6 Southeast Asia
- 8.4.7 India
- 8.4.8 Australia
9 Latin America
- 9.1 Latin America CRM197 Market Size (2017-2028)
- 9.2 Latin America CRM197 Market Size by Type
- 9.2.1 Latin America CRM197 Market Size by Type (2017-2022)
- 9.2.2 Latin America CRM197 Market Size by Type (2023-2028)
- 9.2.3 Latin America CRM197 Market Share by Type (2017-2028)
- 9.3 Latin America CRM197 Market Size by Application
- 9.3.1 Latin America CRM197 Market Size by Application (2017-2022)
- 9.3.2 Latin America CRM197 Market Size by Application (2023-2028)
- 9.3.3 Latin America CRM197 Market Share by Application (2017-2028)
- 9.4 Latin America CRM197 Market Size by Country
- 9.4.1 Latin America CRM197 Market Size by Country (2017-2022)
- 9.4.2 Latin America CRM197 Market Size by Country (2023-2028)
- 9.4.3 Mexico
- 9.4.4 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa CRM197 Market Size (2017-2028)
- 10.2 Middle East & Africa CRM197 Market Size by Type
- 10.2.1 Middle East & Africa CRM197 Market Size by Type (2017-2022)
- 10.2.2 Middle East & Africa CRM197 Market Size by Type (2023-2028)
- 10.2.3 Middle East & Africa CRM197 Market Share by Type (2017-2028)
- 10.3 Middle East & Africa CRM197 Market Size by Application
- 10.3.1 Middle East & Africa CRM197 Market Size by Application (2017-2022)
- 10.3.2 Middle East & Africa CRM197 Market Size by Application (2023-2028)
- 10.3.3 Middle East & Africa CRM197 Market Share by Application (2017-2028)
- 10.4 Middle East & Africa CRM197 Market Size by Country
- 10.4.1 Middle East & Africa CRM197 Market Size by Country (2017-2022)
- 10.4.2 Middle East & Africa CRM197 Market Size by Country (2023-2028)
- 10.4.3 Turkey
- 10.4.4 Saudi Arabia
- 10.4.5 UAE
11 Key Players Profiles
- 11.1 Pfizer Inc.
- 11.1.1 Pfizer Inc. Company Details
- 11.1.2 Pfizer Inc. Business Overview
- 11.1.3 Pfizer Inc. CRM197 Introduction
- 11.1.4 Pfizer Inc. Revenue in CRM197 Business (2017-2022)
- 11.1.5 Pfizer Inc. Recent Developments
- 11.2 Ligand Pharmaceuticals
- 11.2.1 Ligand Pharmaceuticals Company Details
- 11.2.2 Ligand Pharmaceuticals Business Overview
- 11.2.3 Ligand Pharmaceuticals CRM197 Introduction
- 11.2.4 Ligand Pharmaceuticals Revenue in CRM197 Business (2017-2022)
- 11.2.5 Ligand Pharmaceuticals Recent Developments
- 11.3 CanSino Biologic
- 11.3.1 CanSino Biologic Company Details
- 11.3.2 CanSino Biologic Business Overview
- 11.3.3 CanSino Biologic CRM197 Introduction
- 11.3.4 CanSino Biologic Revenue in CRM197 Business (2017-2022)
- 11.3.5 CanSino Biologic Recent Developments
- 11.4 Beijing Kexing Biology Product
- 11.4.1 Beijing Kexing Biology Product Company Details
- 11.4.2 Beijing Kexing Biology Product Business Overview
- 11.4.3 Beijing Kexing Biology Product CRM197 Introduction
- 11.4.4 Beijing Kexing Biology Product Revenue in CRM197 Business (2017-2022)
- 11.4.5 Beijing Kexing Biology Product Recent Developments
- 11.5 Scarab Genomics
- 11.5.1 Scarab Genomics Company Details
- 11.5.2 Scarab Genomics Business Overview
- 11.5.3 Scarab Genomics CRM197 Introduction
- 11.5.4 Scarab Genomics Revenue in CRM197 Business (2017-2022)
- 11.5.5 Scarab Genomics Recent Developments
- 11.6 Xpress Biologics
- 11.6.1 Xpress Biologics Company Details
- 11.6.2 Xpress Biologics Business Overview
- 11.6.3 Xpress Biologics CRM197 Introduction
- 11.6.4 Xpress Biologics Revenue in CRM197 Business (2017-2022)
- 11.6.5 Xpress Biologics Recent Developments
- 11.7 Fina Biosolutions
- 11.7.1 Fina Biosolutions Company Details
- 11.7.2 Fina Biosolutions Business Overview
- 11.7.3 Fina Biosolutions CRM197 Introduction
- 11.7.4 Fina Biosolutions Revenue in CRM197 Business (2017-2022)
- 11.7.5 Fina Biosolutions Recent Developments
- 11.8 Eubiologics
- 11.8.1 Eubiologics Company Details
- 11.8.2 Eubiologics Business Overview
- 11.8.3 Eubiologics CRM197 Introduction
- 11.8.4 Eubiologics Revenue in CRM197 Business (2017-2022)
- 11.8.5 Eubiologics Recent Developments
- 11.9 EirGenix Inc.
- 11.9.1 EirGenix Inc. Company Details
- 11.9.2 EirGenix Inc. Business Overview
- 11.9.3 EirGenix Inc. CRM197 Introduction
- 11.9.4 EirGenix Inc. Revenue in CRM197 Business (2017-2022)
- 11.9.5 EirGenix Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Author Details
- 13.3 Disclaimer